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Development/Plasticity/Repair
Neuronal RAR Signaling Modulates PTEN Activity Directly
in Neurons and via Exosome Transfer in Astrocytes to
Prevent Glial Scar Formation and Induce Spinal Cord
Regeneration
Maria B. Goncalves,1 Tony Malmqvist,1 Earl Clarke,1 Chantal J. Hubens,1 John Grist,1 Carl Hobbs,1 XDiogo Trigo,1
X Mårten Risling,2 Maria Angeria,2 Peter Damberg,3 Thomas P. Carlstedt,1 and Jonathan P.T Corcoran1
1The Wolfson Centre for Age-Related Diseases, King’s College London, Guy’s Campus, London SE1 1UL, United Kingdom, 2Experimental Traumatology,
Department of Neuroscience, Karolinska Institutet, Stockholm SE-17177, Sweden, and 3Karolinska Experimental Research and Imaging Centre,
Department of Clinical Science, Intervention and Technology, Karolinska Universitetssjukhuset, Stockholm SE-17177, Sweden
Failure of axonal regeneration in the central nervous system (CNS) is mainly attributed to a lack of intrinsic neuronal growth programs
and an inhibitory environment from a glial scar. Phosphatase and tensin homolog (PTEN) is a major negative regulator of neuronal
regeneration and, as such, inhibiting its activity has been considered a therapeutic target for spinal cord (SC) injuries (SCIs). Using a novel
model of rat cervical avulsion, we show that treatment with a retinoic acid receptor  (RAR) agonist results in locomotor and sensory
recovery. Axonal regeneration from the severed roots into the SC could be seen by biotinylated dextran amine labeling. Light micrographs
of the dorsal root entry zone show the peripheral nervous system (PNS)–CNS transition of regrown axons. RAR agonist treatment also
resulted in the absence of scar formation. Mechanism studies revealed that, in RAR-agonist-treated neurons, PTEN activity is decreased
by cytoplasmic phosphorylation and increased secretion in exosomes. These are taken up by astrocytes, resulting in hampered prolifer-
ation and causing them to arrange in a normal-appearing scaffold around the regenerating axons. Attribution of the glial modulation to
neuronal PTEN in exosomes was demonstrated by the use of an exosome inhibitor in vivo and PTEN siRNA in vitro assays. The dual effect
of RAR signaling, both neuronal and neuronal– glial, results in axonal regeneration into the SC after dorsal root neurotmesis. Targeting
this pathway may open new avenues for the treatment of SCIs.
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Introduction
Spinal cord injury (SCI) often results in permanent paralysis,
largely as a result of the failure of the injured axons to regenerate
in the adult mammalian CNS. The major impediments to axonal
regeneration are unfavorable neuron-intrinsic mechanisms and
the glia scar, which not only represents a physical barrier (Wan-
ner et al., 2013) in which axonal tips get trapped, but also creates
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Significance Statement
Spinal cord injuries (SCIs) often result in permanent damage in the adult due to the very limited capacity of axonal regeneration.
Intrinsic neuronal programs and the formation of a glial scar are the main obstacles. Here, we identify a single target, neuronal
retinoic acid receptor  (RAR), which modulates these two aspects of the postinjury physiological response. Activation of RAR
in the neuron inactivates phosphatase and tensin homolog and induces its transfer into the astrocytes in small vesicles, where it
prevents scar formation. This may open new therapeutic avenues for SCIs.
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an inhibitory extrinsic milieu due to molecules that are secreted
by its components (Shearer and Fawcett, 2001; Silver and Miller,
2004). Axonal regeneration is shaped by neuronal and glial cues
and an interchange between them (Toy and Namgung, 2013;
Williams et al., 2015), so an ideal drug would tackle this cross talk
for therapeutic benefit.
We have studied here axonal regeneration in a rat SCI result-
ing from cutting and subsequently implanting the cut end of
dorsal roots into the SC. This type of injury is clinically relevant
and analogous to the intraspinal plexus lesions that often occur as
a result of motorcycle accidents and cause major functional def-
icits. Centrally projecting sensory axons of the severed dorsal root
regenerate in the peripheral division of the dorsal root, but are
normally arrested at the transitional region between the PNS and
the CNS, the dorsal root entry zone (DREZ), and fail to re-enter
the spinal dorsal horn (Carlstedt, 1985). The functional conse-
quence is obviously permanent loss of sensation. Successful ther-
apy would unequivocally be attributed to regenerating dorsal
root axons growing pass the injury zone and into the SC, thus
restoring sensory function.
A major contributor to regenerative failure is a diminished in-
trinsic capacity of adult axons to grow, based largely on inactivity in
the phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of
rapamycin (mTOR) pathway, which is negatively regulated by phos-
phatase and tensin homolog (PTEN) (Park et al., 2010).
Previous work has shown that retinoic acid receptor 2
(RAR2) signaling stimulates axonal outgrowth (Wong et al.,
2006; Agudo et al., 2010) and that this occurs via PI3K signaling.
Retinoic acid (RA) plays an essential role in the survival and
differentiation of the vertebrate CNS and stimulates both neurite
number and length in embryonic neuronal types (Maden, 2001).
In the adult, RA-responsive elements are locally activated in the
regenerating rat nerve after peripheral nerve injury (Zhelyaznik
et al., 2003). In embryonic DRG neurons, RAR2 mediates neu-
rite outgrowth induced by RA (Corcoran et al., 2000) and, in
adult spinal cord explants, where RAR2 is absent, exogenous
RAR2 stimulates neurite outgrowth (Corcoran et al., 2002).
Furthermore, the delivery of RAR2 to adult neurons induces ax-
onal regeneration programs within injured neurons and encourages
axonal growth in the inhibitory CNS (Yip et al., 2006). Here, we
show that activation of RAR signaling after dorsal root injury inac-
tivates neuronal PTEN by shifting membrane PTEN into the cyto-
plasm and also inducing increased release of PTEN in exosomes.
Given the importance of exosomes in neuron–glia communication
(Chivet et al., 2013) and that cell-to-cell biological activity has been
reported for PTEN exported in exosomes (Putz et al., 2012), we have
explored their role in axonal regeneration. We found that neuronal
PTEN can modulate astrocyte activity via exosome transfer by pre-
venting their exacerbated proliferation. This results in the absence of
an astrocytic scar after SCI and favors axonal regeneration in that the
astrocytes rearrange in sleeves or tunnels that encourage the regrow-
ing axons to follow centrally.
In summary, we found that RAR signaling alters intrinsic
and extrinsic signaling pathways to induce true axonal regenera-
tion of primary sensory neurons in the CNS after dorsal root
rhizotomy and reimplantation into the SC, resulting in sensory
and locomotor recovery. The RAR pathway modulates PTEN
signaling directly in neurons and via neuron– glia exosome trans-
fer to create a permissive environment for axonal regrowth.
Materials and Methods
Surgery and drug treatments. All rat experiments were approved by the
local veterinarian and ethical committees and performed according to
UK Home Office regulations. In male Wistar rats (8 per treatment group
for each set of experiments) C5–C8 and T1 dorsal roots were cut flush
with the SC surface. The cut ends of the dorsal roots were subsequently
introduced through slits in the pia mater and positioned superficially in
the SC adjacent to where they had been cut. Rats were treated with vehicle
or a specific RAR agonist, CD2019 (1 mg/kg, synthesized by Sygnature
Chemical Services), or with the exosome inhibitor GW4869 (1 mg/kg;
Cayman Chemical) (Dinkins et al., 2014) alone or in conjunction with
the RAR agonist by intraperitoneal injection (i.p.) 3 times a week for 4
weeks. At week 2, primary sensory afferents were labeled by injection of
the anterograde tracer biotinylated dextran amine (BDA) in the median
nerve. Animals were culled after 2, 4, or 5 weeks of treatment. Rats were
perfused transcardially with heparinized 0.9% NaCl solution and 4%
paraformaldehyde in 0.1 M phosphate buffer. The cervical cords with
attached DRGs were dissected, rapidly removed, and postfixed with 4%
paraformaldehyde (in 0.1 M phosphate buffer) for at least 2 d at room
temperature. Tissue was then embedded in paraffin wax and 5 m lon-
gitudinal sections cut throughout each block. Sets of consecutive sec-
tions, comprising the lesioned area, were used for immunostainning.
Behavior analysis. The behavioral analysis was performed by experi-
menters blinded to the treatment for 1 week before and for 5 weeks after
injury. In the tape removal test (Bradbury et al., 2002), adhesive tape
(1.5  1 cm) was placed on each forepaw separately and the time taken to
sense (indicated by paw shake) and remove the tape (cutoff time point, 1
min) was scored. For locomotor tasks (Bradbury et al., 2002), rats were
trained to cross a horizontal ladder (18 –100 cm with each rung 5 cm
apart) and the number of forelimb foot slips (off the beam or below the
plane of the ladder) was recorded. Confirmation of injury was obtained
by the poor performance of all animals in tape removal and locomotor
tasks the day after injury. Behavioral responses of treated and control
groups were compared using one-way ANOVA followed by Tukey’s post
hoc test.
Immunohistochemistry and antibodies. Immunohistochemistry was
performed as described previously (Goncalves et al., 2005) Neuronal
cultures were washed with PBS for 1 min, fixed in 4% PFA for 30 min,
washed 3 times for 5 min each in PBS– 0.02% Tween, and incubated in
primary antibody in PBS– 0.02% Tween at 4°C overnight. Primary anti-
body was removed by washing 3 times for 5 min each in PBS– 0.02%
Tween, incubated in the secondary antibody for 1 h at room temperature
in PBS– 0.02% Tween, and then washed in PBS 3 times for 5 min. The
coverslips were then mounted using FluroSave reagent (Merck). For spi-
nal cord tissue, sections were first dewaxed in xylene and 100% IMS,
heated in citric acid (10 mM, pH 6) until boiling, and then washed under
a running tap for 5 min before incubation with primary Ab. Antibodies
used were as follows: mouse monoclonal anti-III tubulin (Promega,
1:1000 for immunohistochemistry and 1:10,000 for Western blotting);
chicken polyclonal anti-GFAP (Abcam, 1:300); rabbit polyclonal anti-
GFAP (DAKO, 1:2500); mouse monoclonal anti-GFAP (Sigma-Aldrich,
1:100); rabbit polyclonal anti-RAR (Santa Cruz Biotechnology, 1:100
for immunohistochemistry and 1:500 for Western blotting); goat poly-
clonal anti-CGRP (Abcam, 1:200); rabbit polyclonal anti-PTEN (Abcam,
1:50); rabbit polyclonal anti-VGLUT1 (Abcam, 1:4000); rabbit poly-
clonal anti-c-Fos (Abcam, 1:300); rat polyclonal anti-synaptophysin (Se-
rotec, 1:200); rabbit polyclonal anti-PTEN (Y184, Abcam, 1:500 for
Western blotting); mouse monoclonal anti-PTEN (26H9, Cell Signaling
Technology, 1:1000 for Western blotting); rabbit polyclonal anti-
phospho-PTEN (Ser380, Cell Signaling Technology, 1:500 for immuno-
histochemistry or 1:1000 for Western blotting); mouse monoclonal
NMDAR2B (S59-36, Abcam, 1:500); rabbit polyclonal anti-Lamin A (H-
102, Santa Cruz Biotechnology, 1:250); and mouse monoclonal anti--
actin (AC-15, Sigma-Aldrich, 1:5000). Secondary antibodies for
immunohistochemistry were Alexa Fluor 594 and Alexa Fluor 488 (1:
1000, Invitrogen). DAPI was used to stain nuclei (1 g/ml, Sigma-
Aldrich). Secondary antibodies for Western blotting were Alexa Fluor
680 (1:5000, Invitrogen) and IR Dye 800CW (1:5000, Li-Cor Biosci-
ences). Quantitative analysis of GFAP-positive cells at the lesion site was
performed as described previously (Herrmann et al., 2010). In brief,
GFAP-positive areas were quantified as the pixels of immunoreactivity
above a threshold level per unit area. The threshold value was set to
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include GFAP-positive signal and to exclude background staining.
Threshold values for a given section and stain remained the same
throughout the study. The number of pixels was measured from the
implantation site of the severed dorsal roots to a distance of 100 m away
from the implantation site. For BDA quantification, positively labeled
axons were measured by mean intensity of immunoreactivity that had
crossed the DREZ and entered the gray matter extending 300 m in-
wards. For synaptophysin and VGLUT1 quantification in the dorsal horn
(lamina I and II for synaptophysin and II and III for VGLUT1), again, the
mean intensity values of immunoreactivity obtained from high-
magnification (63 objective) images of spinal cord sections taken at the
same levels were used. c-Fos quantification was done as described previ-
ously (Yip et al., 2006). At least 10 sections per rat were used for these
quantifications.
Confocal microscopy. Multichannel fluorescence (DAPI-FITC-Texas
Red filter set) images were captured using a Zeiss LSM 700 laser-scanning
confocal microscope with a 63  oil-immersion Aprochromat objective.
Settings for gain, aperture, contrast, and brightness were optimized ini-
tially and held constant throughout each study so that all sections were
digitized under the same conditions of illumination. Channels were im-
aged sequentially to eliminate bleedthrough and multichannel image
overlays were obtained using Adobe Photoshop 7.0. For time-lapse im-
aging analysis, cells were imaged every 15 min for 24 h at 37°C and 5%
CO2. Axiovision software was used to collect information on pixel im-
munoreactivity used for quantitative purposes.
Light micrography. Specimens intended for plastic embedding were
perfusion fixed with 2% glutaraldehyde and rinsed in PBS. After dehy-
dration in a graded series of ethanol, these specimens were embedded in
Durcopan (Fluka). After polymerization, the specimens were cut in 0.5-
m-thick sections on an LKB Ultrotome V and stained with toluidine
blue. Images were obtained with a Nikon E600 microscope with a 60
oil-immersion plan-apo lens and a Nikon Digital Sight DS-U1 camera.
After examination in the light microscope, some specimens were se-
lected for electron microscopy. Ultrathin sections were prepared with a
diamond knife and the LKB Ultrotome and collected on 400 mesh grids.
After contrasting with a saturated solution of uranyl acetate and a 0.08 M
lead citrate solution, the sections were examined in an FEI Morgagni
transmission electron microscope.
Diffusion MRI tractography. Specimens for ex vivo MRI were fixed in
paraformaldehyde and transferred to Fombin in a plastic syringe and
mounted in a 16 mm coil (Rapid Biomedical) in a 9.4 T MRI system
(Agilent Technologies). Diffusion-weighted data were recorded over-
night using a spin echo sequence (TR  4 s, TE  18.17 ms, b  1250
s/mm 2, 70 contiguous slices of 0.15 mm thickness, matrix  192  192
FOV  19.2  19.2 mm 2, ucl42 scheme, zero-filled to 256  256 before
reconstruction). Tractography DSI studio DTI reconstruction was per-
formed using the following tracking parameters: termination index FA,
threshold, 90° angular threshold, step size 0.05, subvoxel seed position,
trilinear direction interpolation, and the streamline (Euler) tracking
algorithm.
Primary neuronal cell cultures. Mouse primary cortical neurons were
prepared as described previously (Goncalves et al., 2013). Cells were plated
onto 10 g/ml poly-D-lysine-coated 100 mm dishes at a density of 6  106
cells/dish. Cells were cultured in neurobasal medium (Invitrogen) contain-
ing 2% (v/v) B27 serum-free supplement, 2 mM L-glutamine, 1.5% glucose,
penicillin (100 units/ml), and streptomycin (100 g/ml) at 37°C in a humid-
ified atmosphere of 5% CO2/95% air. Cultures were used after 24 or 72 h and
were 98% neurons judged by III-tubulin staining. Treatments were as
follows: mouse primary cortical cultures [0 d in vitro (DIV)] were treated
with 0.1 M CD2019 for 72 h as indicated. For identification of PTEN-
transfected neurons, cells were visualized with CellTracker Red CMPTX
(Life Technologies), which was added according to the manufacturer’s in-
structions at the same time as treatments and placed in an incubator attached
to a confocal microscope as described above. Pictures were taken on live cells
every 30 min for 90 min. Culture conditions were three wells per treatment
performed three times.
Transfection of cortical neurons. Cortical neurons were plated at 1 
10 6 cells/well in six-well plates. Separate solutions of cDNA in OptiMEM
(Life Technologies) and Lipofectamine 2000 transfection reagent (Life
Technologies) in OptiMEM were prepared at a ratio of 1:1.9 (g DNA:l
Lipofectamine) and allowed to stand for 5 min. They were then mixed
and incubated at room temperature for 20 min before addition to the
cells in a total volume of 2 ml. After 5 h, 1.5 ml of medium was removed
from each well and replaced with fresh 1.5 ml aliquots of neurobasal
medium containing L-glutamine, glucose, penicillin, streptomycin, and
B27 supplement (all from Life Technologies). Human PTEN expression
constructs was obtained from OriGene Technologies.
Mouse cortical neurons (10 DIV) were transfected with PTEN siRNA
(SR413443) using siTRAN (1.0 transfection reagent; OriGene), accord-
ing to the manufacturer’s protocol. In brief, 1.5  10 12 M siRNA was
added to each well and incubated for 72 h. Knock-down of PTEN was
confirmed by Western blotting in cells and in isolated exosomes. As a
control, scrambled siRNA was added to wells (universal scrambled neg-
ative control siRNA duplex). These cells were then treated with either
CD2019 (0.1 M) or with vehicle for 72 h and PTEN levels were measured
in both exosomes and cell lysates, as described previously. Exosomes
from similar preparations of transfected mouse cortical neurons treated
either with CD2019 (0.1 M) or with vehicle for 72 h were isolated and
used to treat astrocytes in culture to measure proliferation.
Neurite outgrowth assay. Exosomes isolated from CD2019- (0.1 M)
and vehicle-treated astrocyte primary cultures were added to primary
cortical neuron cultures in a one-to-one ratio (the quantity of exosomes
isolated from one well of astrocytes was used to treat one well of neu-
rons). After 72 h, the cells were fixed in 4% PFA, permeabilized with 0.1%
Triton X-100 for 4 min, and stained with Alexa Fluor 488 Phalloidin
(Invitrogen, 1:40). Images were captured as described before (in the
“Confocal microscopy” section). Three fields capturing a minimum of 10
neurons were taken per coverslip in at least three coverslips for each
culture condition. The images were processed using ImageJ software.
The length of the longest neurite in each neuron was measured. Statistical
analysis was done with one-way ANOVA followed by Tukey’s test.
Astrocyte cultures. Primary mixed glial cultures were prepared as de-
scribed previously (Goncalves et al., 2013) using a modified protocol.
Briefly, mixed glial cultures were obtained from the cortices of postnatal
(P) mice (P5–P8). Cultures were maintained at 37°C (5% CO2/95% O2)
in medium containing 15% fetal bovine serum (FBS) (Invitrogen) and
1% penicillin-streptomycin (Sigma-Aldrich) for 10 –14 d. Microglial
cells were then harvested by forceful shaking for 1 min by hand. After
harvesting of microglia was done every 3 d for 9 d, 0.25% trypsin EDTA
was added to each flask for 15 min. Cells were then centrifuged at 2000
rpm for 10 min and plated on poly-D-lysine-coated coverslips (24-well
plates) or 96-well plates in 5% FBS.
Cell fractionation. All centrifuge steps were performed at 4°C. Mouse
cortical neurons were harvested in hypotonic buffer (10 mM HEPES, pH
7.5, 10 mM KCl, 3 mM MgCl2, 1 mM NA3VO4, 1 mM NaF, and EDTA-free
protease inhibitor mixture; Roche). Cell lysates were left on ice for 20 min
and then passed through a 25 Ga needle 10 and then centrifuged at
720  g for 5 min. The supernatant (SN1) was collected and the pellet
(P1, nuclear pellet) was washed once in hypotonic buffer, centrifuged
again at 720  g for 5 min, and then resuspended in 2 Laemmli sample
buffer. SN1 was further centrifuged at 10,000  g and the supernatant
(SN2) was collected and the pellet (P2, mitochondrial pellet) was dis-
carded. SN2 was then centrifuged at 90,000  g for 1 h. The supernatant
(SN3, cytosolic fraction) was collected and assayed for protein concen-
tration. The pellet (P3, membrane fraction) was resuspended in Triton
buffer (10 mM Tris, pH 7.4, 500 mM NaCl, 1 mM EDTA, 1% Triton X-100,
1 mM NA3VO4, 1 mM NaF, and EDTA-free protease inhibitor mixture;
Roche). After resuspension, protein lysates were centrifuged for 30 min
at 16,000  g and the supernatant (SN4, membrane proteins) was col-
lected. Whole-cell lysates were made by incubating cell pellets directly in
RIPA buffer (25 mM Tris, pH 7.4, 150 mM NaCl, 1% NP-40, 1% sodium
deoxycholate, 1 mM NaF, 1 mM Na3VO4, 0.1% SDS, 1 mM PMSF, 10 mM
EDTA, supplemented by EDTA-free protease inhibitor mixture). Protein
concentrations were determined with the BCA Protein Assay (Pierce).
Western blotting. Proteins were separated by SDS-PAGE on 10% (w/v)
polyacrylamide gels and then transferred to a 0.45 m pore size nitrocel-
lulose membrane (BA85; Schleicher and Schuell) using a Trans-Blot SD
Semi-Dry Transfer Cell (Bio-Rad Laboratories) Nitrocellulose mem-
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branes were incubated in blocking solution consisting of 5% (w/v)
skimmed milk powder in PBS-Tween-20 (0.1%, w/v) (PBS-T) for 1 h at
room temperature, followed by incubation with the appropriate primary
antibody diluted in blocking solution overnight at 4°C. Membranes were
washed in PBS-T and then incubated with species-specific secondary
antibodies in blocking solution for 1 h at room temperature in the dark,
after which time the membranes were washed as above. Protein levels
were corrected for loading differences by normalizing against -actin
levels. Proteins were detected by scanning at 700 and 800 nm using the
Odyssey detection system (LI-COR Biosciences).
Exosomes. Exosomes were prepared from conditioned media of
cortical neurons treated with the RAR agonist CD2019 (0.1 M) or
dimethylsulfoxide vehicle using Total Exosome Isolation (TEI) reagent
(Invitrogen) in accordance with the manufacturer’s instructions. Condi-
tioned media were centrifuged at 2000  g for 30 min at 4°C to remove
cells and cell debris and the resulting supernatants were mixed with 0.5
volumes of TEI reagent, incubated overnight at 4°C and centrifuged at
10,000  g at 4°C for 1 h. Exosome pellets were twice washed by resus-
pension in ice-cold PBS followed by centrifugation at 100,000  g at 4°C
for 1 h. For Western blots, pellets were lysed in a buffer containing 25 mM
Tris-HCl, pH 7.4, 150 mM NaCl 1% Triton X-100, 1 mM EDTA, 10%
(v/v) glycerol, 1 mM phenylmethylsulfonylfluoride, 1 mM sodium fluo-
ride, and EDTA-free protease inhibitor mixture (Roche). Lysates were
triturated 10 times through 29 Ga needles. As a control for exosomal
proteins, CD2019- and vehicle-treated cortical neurons were washed
with PBS, collected, and lysed as above. All lysates were centrifuged for 15
min at 21,000  g at 4°C and the protein concentration in the superna-
tants was determined with Pierce BCA Protein Assay reagents. Unused
intact exosomes were stored at 80°C as PBS suspensions. For exosome
injections at the implantation site of severed dorsal roots, a pool of
exosomes isolated from 75 cm 2 Thermo Scientific cell-culture-treated
flasks with filter caps of 99% confluent mouse cortical neurons that had
been treated with vehicle or CD2019 as before was used. A single unilat-
eral injection of 10 l of exosome stock was made manually using a 20 l
Hamilton syringe at 0.5 l min 1 and the needle was left in place for 5
min to limit exosome diffusion through the needle tract.
Cell proliferation assay. Astrocytes plated in 96-well plates at 60% con-
fluency were treated with either CD2019 (0.1 M) or dimethylsulfoxide
(1 l) or with exosomes isolated from the conditioned medium of
CD2019 (0.1 M)-treated or dimethylsulfoxide-treated cortical neurons.
In a similar setup, astrocytes were treated with exosomes isolated from
siRNA (scrambled or PTEN)-transfected cortical neurons cultured
with CD2019. After overnight incubation at 37°C in 5% CO2, cell prolif-
eration was determined by the CellTiter 96 Non-Radioactive Cell Prolif-
eration Assay kit (Promega) in accordance with the manufacturer’s
instructions. Aliquots of 15 l of dye were added to the cells for 4 h.
Solubilization/stop solution (100 l) was added overnight and the absor-
bance at 570 nm was read using a plate reader.
Data analysis. Data were analyzed using Student’s t test with one-way
ANOVA followed by Tukey’s or Fisher’s test, using SigmaStat software
(SPSS). Comparisons were made between appropriate groups and differ-
ences were considered statistically significant at the level of p  0.05.
Results are given as mean  SE and p values are provided as summary
statistics.
Results
RAR agonist induces functional recovery after cervical
dorsal root injury
We modeled in the rat a human avulsion injury in which the sensory
dorsal roots were cut flush with the SC surface leading to the left
forelimb at C5–C8 and T1 (Fig. 1A). The cut ends of the dorsal roots
were subsequently introduced through slits in the pia mater and
positioned superficially in the SC adjacent to where they had been
cut (Fig. 1A). The motor roots were left intact because they have the
capacity for some regeneration after this type of injury (Cullheim et
Figure 1. The RAR agonist promotes functional recovery and axonal regeneration. A, Schematic of the injury performed, in which C5–T1 were cut and grafted back into the SC Rats were assessed
in behavioral tasks before and for 5 weeks after avulsion. B, C, In a tape removal task, the time taken to sense and remove the tape by the lesioned forelimbs was measured and significantly lower
latencies were observed with the injured forelimbs of RAR agonist (1 mg/kg, i.p., every other day)-treated rats compared with vehicle-treated ones, from week 3 of treatment. D, In locomotor
tasks, the number of foot slips in a horizontal ladder made by the injured forelimb of RAR-agonist-treated rats was markedly lower than that of vehicle-treated rats from week three. Data represent
mean  SEM.**p  0.005; ***p  0.001, one-way ANOVA followed by Tukey’s post hoc test. E, F, BDA-labeled axons double stained with either III tubulin (E) or CGRP (F ) can be seen along the
dorsal root and crossing the DREZ in RAR-agonist-treated rats, but not in vehicle-treated ones. Scale bars: left, 100 m; E, right insets, 50 m, left insets 80 m; F, insets, 80 m. G, Quantification
of BDA-labeled axons that cross the DREZ into the dorsal horn up to 300 m into the gray matter. H, Schematic representation of the median nerve (BDA injection site) ascending tracts into the
brainstem in the cuneate nucleus (CN). I, Absence of BDA in CN nerve tracts in an RAR-treated rat. Results are mean  SEM. **p  0.005, Student’s t test.
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al., 1989). Three days after surgery, rats were injected intraperitone-
ally with an RAR agonist (1 mg/kg) every other day for a period of
4 weeks. All animals were trained preoperatively for 2 weeks in sen-
sory and locomotor tests, which consisted of the sensing and remov-
ing of sticky tape from the paw and the number of foot slips made
walking across a horizontal ladder. Performances were recorded the
day before surgery, the day after surgery, and every following week
until postoperative week five (inclusive). C5–T1 rhizotomy (Fig. 1A)
produced an immediate, complete functional loss in the pertinent
forelimb. Although there was no recovery in the vehicle-treated an-
imals, there was a significant improvement in the agonist-treated
ones from the third week of treatment (Fig. 1B–D).
RAR agonist induces axonal regeneration and reduced glial
scar size in avulsed rats
To confirm that the functional recovery was the result of true
axonal regeneration rather than sprouting and/or compensation
from spared axons, the median nerve was injected with the tracer
BDA 3 weeks before the rats were killed at week six. Spinal cords
with DRGs and roots attached were dissected out for histology
analysis. To observe regeneration only in sensory roots C6 –C8
and avoid including misleading sprouting from intact roots ad-
jacent to the injury site, we used calcitonin gene-related peptide
(CGRP), which is widely expressed in sensory neurons and is
upregulated in regenerating axons (Li et al., 2004), along with
BDA double labeling. No BDA-labeled axons were found to have
crossed the DREZ in vehicle-treated animals, whereas robust
regeneration could be seen in RAR-agonist-treated rats (Fig.
1E,F). In these, a significant number of sensory axons, colabeled
with III tubulin and CGRP, could be seen projected from the
dorsal root into the dorsal horn (Fig. 1E,F). Quantification of
BDA-labeled axons 300 m into the dorsal horn confirmed the
significant degree of regeneration in agonist compared with
vehicle-treated animals (Fig. 1G). To rule out sprouting from
spared axons, we then looked at BDA-labeled nerve tracts in the
cuneate nucleus in RAR-agonist-treated rats. The absence of
staining in these ascending nerve tracts in the brainstem (Fig.
1H, I) confirmed a complete lesion and that the BDA-positive
axons present in the dorsal horn represent regenerating axons.
We next sought further confirmation of axonal regeneration
by examining various markers of regeneration and synaptic con-
nectivity. All rats were subject to noxious heat stimuli in their
forelimbs, which induces c-Fos activation in postsynaptic neu-
rons in the superficial laminae of the dorsal horn (Hunt et al.,
1987). We found that immunoreactivity of c-Fos was greater in
laminae I and II of the dorsal horn in RAR-agonist-treated rats
than in vehicle-treated rats (Fig. 2A,B). Next, we looked at CGRP
in conjunction with synaptophysin, a presynaptic terminal
marker. CGRP nociceptors restrict their terminals to lamina I
and the outer aspect of lamina II and the reestablishment of syn-
aptic connections to the most appropriate target region is para-
mount to achieving functional recovery (Sanes and Yamagata,
1999). Analysis of synapse formation by double labeling CGRP-
positive axons for synaptophysin demonstrated extensive ectopic
synapses in the outer laminae of the dorsal horn in SC segments
connected to the injured dorsal roots, but only in RAR-agonist-
treated animals (Fig. 2C,D). Furthermore, motoneurons in the
ventral horn of treated animals exhibited higher levels of RAR
and were notably more densely surrounded by synaptophysin
vesicles (Fig. 2E). This may suggest that RAR signaling might
either restore or preserve synaptic connections between dorsal
and ventral horn neurons. We next analyzed the recovery of
mechanoceptive and proprioceptive synapses, which are lost as a
consequence of nerve injury (Alvarez et al., 2011). We found that
VGLUT1, which is the principal excitatory neurotransporter
from primary afferents onto spinal neurons, was strongly ex-
pressed in RAR-agonist-treated rats, but not in vehicle-treated
ones (Fig. 2F–H).
To further assess the presence of regenerated axons in the SC,
plastic-embedded specimens from RAR-treated animals of the
SC and implanted dorsal roots were cut longitudinally with the
implanted root. Light micrographs showed that, at the site of
implantation, bundles of myelinated fibers could be followed
from the root into the SC (Fig. 3A,B). The nerve fibers in this
region were seen to be typically separated from each other by
fibrous astrocytic processes. Several histological features corrob-
orate that true regeneration from the root into the SC has oc-
curred: the finding of typical transitional nodes of Ranvier where
the myelinated fiber changes from a peripheral to a central type of
myelin and the presence of juxtaposed astrocytic nucleus
(Berthold et al., 1993; Berthold and Carlstedt, 1977a, 1977b; Fig.
3A,B). Importantly, the surrounding tissue lacks the cellular in-
filtrate of a glial scar, whichis typically formed by a complex sys-
tem of interacting cell types (Cregg et al., 2014).
Electron microscopy also showed PNS to CNS transition of
myelinated fibers. In ultrathin sections adjacent to the semithin
sections for light microscopy, most of the proximal PNS type of
paranode covered by basement menbrane occurred between lon-
gittudinally arranged astrocytic processes (Fig. 3C). Because glial
scar formation inhibits axon regrowth (Silver and Miller, 2004)
but a contained number of astroglia are required for essential
functions of tissue repair and neuroprotection (Bush et al., 1999;
Faulkner et al., 2004), we looked closer at the GFAP population at
and beyond the DREZ in each animal group. Whereas BDA-
labeled axons stopped at the glial barrier formed at the DREZ in
vehicle-treated rats, they extended all the way through into the
dorsal horn in RAR-agonist-treated rats, which exhibited a
considerably smaller population of GFAP-positive cells in the
dorsal root adjacent to the implantation site (Fig. 4A,C). High-
resolution imaging showed that the morphology and density of
the glial cells was remarkably different, with a glial scar formed by
hypertrophic astrocytes with mesh-like entangled processes in
vehicle-treated rats, whereas in RAR-agonist-treated rats, elon-
gated tunnel-like astrocytes were seen bridging the PNS and CNS
(Fig. 4B). The phenotypes of the glia observed in each animal
group have been well characterized and ascribed to regeneration
nonpermissive scar and permissive glia axonal support network,
respectively (Cregg et al., 2014).
Additional evidence for axonal regeneration from the severed
dorsal roots into the SC in RAR-agonist-treated animals was
obtained using a 9.4 T MRI scanner. The vector pictures of voxels
representative of water diffusion seen in the animal treated with
an RAR agonist showed a predominant orientation indicative of
anatomical structures that could be nerve fibers and/or astrocytic
processes that are aligned through the white matter and the re-
plant (Fig. 5A,C), as suggested in the histology.
In contrast, it was not possible to find any signs of connectivity
between the white matter and the replant in the animal treated
with the control vehicle (Fig. 5B,D). Together with the histology
and functional data, these results, although not conclusive per se,
provide support for axonal regeneration and connectivity.
RAR signaling modulates axonal regeneration via
PTEN phosphorylation
The notable modulation of glial cell activity and axonal regener-
ation induced by RAR agonist treatment could only be ex-
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Figure 2. RAR agonist induces peripheral afferent stimulation and activation of postsynapticneurons in the spinal cord. A, B, After noxious heat stimulation, a significantly higher number of
c-Fos-immunoreactive nuclei were detected in the SC of lesioned RAR-agonist-treated rats compared with vehicle-treated ones. Scale bars: A, 50 m; B, 75 m. C, D, Expression of presynaptic
marker synaptophysin and CGRP in the dorsal horn laminae I and II (LI and LII) is much higher in RAR-agonist-treated rats then in vehicle-ones. Scale bar, 20 m. E, High levels of RAR and
synaptophysin are seen in the ventral horn neurons (dotted lines) in RAR-agonist-treated rats but not in vehicle ones. Scale bar, 10 m. F–H, Higher expression of VGLUT1 in neurons in the dorsal
horn (LII and LIII) in RAR-agonist-treated rats than in vehicle-treated rats. Scale bars: F, 50 m; G, 100 m. CC, Central canal. Results are mean  SEM. ***p  0.001, Student’s t test (B, D, H ).
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plained if RAR signaling acts on a key pathway determining
regeneration. PTEN is a major contributor to adult regenerative
failure in the CNS, in which membrane-bound PTEN inhibits
PI3K (Maehama and Dixon, 1998; Carracedo and Pandolfi, 2008;
Park et al., 2010).
We showed previously that RAR signaling stimulates the PI3K
pathway in cultured cerebella neurons via a nongenomic mecha-
nism, resulting in neurite outgrowth (Agudo et al., 2010). Here, we
postulated that activation of RAR signaling after nerve injury could
promote regeneration via inactivation of PTEN. To confirm this, we
cultured cortical neurons and stimulated them for 72 h with an
RAR agonist (0.1 M). This induced an increase in expression of
RAR in the cytoplasm and a decrease in the membrane compared
with vehicle-treated cultures (Fig. 6A,B). Interestingly, this corre-
lated with the levels of PTEN, which significantly increased in the
cytoplasm and decreased in the membrane (Fig. 6A,B). We also
found that, in RAR-treated cultures, there was an increase in cyto-
plasmic phosphorylated PTEN (Fig. 6A,B), which represents an in-
active form of the protein (Ross and Gericke, 2009). To confirm
these data and to rule out a transcriptional upregulation of PTEN, we
performed live-cell imaging using GFP-PTEN under control of a
CMV promoter. This was transfected into neurons and the cyto-
plasm visualized by using a red fluorescent cell tracker. At time 0,
PTEN could be detected in the neurites and
there was very little overlap with the cell
tracker, suggesting that PTEN was located in
the membranes (Fig. 6C). Next, we stimu-
lated the cultures with 0.1 M RAR ago-
nist. With increasing time (0–60 min), the
PTEN became located in the cytoplasm, as
shown by its overlap with the cell tracker
and concomitant decrease in the neurites,
and eventually the majority was found in the
neuronal cell body (90 min) (Fig. 6C). We
also found that RAR agonist treatment re-
sulted in increased nuclear PTEN, both total
and phosphorylated. Together, these results
show that RAR signaling modulates the
cellular distribution of PTEN.
RAR signaling modulates neuron–
glial cross talk via PTEN transfer
in exosomes
The data above suggest that an inactivation
of PTEN is in part responsible for the axonal
regeneration that we see in the injured neu-
rons. Because we had found that the scar size
was significantly reduced in agonist-treated
compared with vehicle-treated animals (Fig.
4D), we inferred that RAR signaling might
also affect scar formation. A possible mech-
anism of action would be to stop the forma-
tion of the scar either by a direct action of the
agonist on the glial cells or an indirect
mechanism via neuronal–glial signaling.
Exosomes take part in intercellular commu-
nication (Chivet et al., 2013) and it has been
shown recently that this also applies to
axonal regeneration in the PNS (Lopez-
Verrilli et al., 2013). Because PTEN regu-
lates astrocyte proliferation (Fraser et al.,
2004) and can reduce cell proliferation via
exosome trafficking (Putz et al., 2012), we
postulated that the RAR agonist might induce neuronal secretion
of PTEN in exosomes that target astrocytes and hamper their prolif-
eration. To test this, we extracted exosomes from culture media of
neurons that had been treated with and without RAR agonist for
72 h. PTEN content was measured in each pool of exosomes and we
found that the ones treated with CD2019 were significantly enriched
in PTEN (Fig. 7A,B). Next, we added exosomes to glial cultures and
measured proliferation after 24 h. In RAR-agonist-treated cultures,
there was little or no effect on proliferation compared with vehicle-
treated cultures (Fig. 7C). In exosome-treated cultures from non-
CD2019-treated neurons, proliferation was comparable to that of
vehicle-treated neurons. However, in cultures treated with exo-
somes from agonist-stimulated neurons, there was a dramatic
decrease in astrocyte number (Fig. 7C). To confirm that this was
indeed the result of neuronal-exosome-secreted PTEN that had
been taken up by astrocytes, we repeated the experiment and
immunostained the cultures for PTEN. We found that little or no
PTEN could be detected in the astrocytes except for the ones
cultured with exosomes from CD2019-treated neurons, in which
there was a remarkable increase in PTEN expression (Fig. 7D). To
verify that CD2019 did not affect endogenous PTEN in astrocytes
directly via an intracellular or exosome-mediated effect, astrocyte
cultures were treated with the RAR agonist and exosomes were
Figure 3. Regeneration from the PNS into the CNS. Light micrograph (LM) of longitudinal section through dorsal root implan-
tation into a pocket of SC in plastic-embedded specimen. There are signs of previous trauma, such as lack of a glia limitans,
vacuoles, and posttraumatic edema. Note also the lack of a glia scar formation at the site of SC implantation. Inset shows a bundle
of myelinated fibers crossing from PNS to CNS. The most proximal peripheral paranodes are surrounded by astrocytic processes. A
transitional PNS–CNS node of Ranvier (NR) is seen with atypical adjacent astrocytic nucleus (AN). Scale bar, 100 m. B shows a
diagram of A. C, EM micrograph of ultrathin section from the same region as shown in LM (A). The most proximal PNS type of
paranode (indicated by the asterisk) with a typical Schwan cell basement membrane. The paranode, when in this region, is typically
surrounded by fibrous astrocytic processes that have arranged themselves in “tunnel”-like formations. The basement membrane
seen at the surface of this tunnel is a reflection of the Schwann cell basement membrane of the paranode, which at the composite
PNS–CNS node of Ranvier, leaves the pertinent nerve fiber and follows the outline of the glia tunnel. The arrow indicates a basal
lamina. Scale bar, 500 nm.
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extracted from the medium after 72 h.
Western blots of cell lysates showed no
difference in PTEN nor phosphorylated
PTEN expression compared with control
cultures (Fig. 7E,F). Similarly, little or no
PTEN was detected in the exosomes
treated with or without the RAR agonist
(data not shown). This suggests that it is a
neuron– glial transfer of PTEN in exo-
somes that is the operative mechanism by
which RAR activation results in in-
creased astrocytic PTEN.
To ascertain whether a similar mech-
anism occurs in vivo, we next looked at
PTEN in astrocytes in the perilesioned
area of avulsed rats that had been
treated with either vehicle or the RAR
agonist. An increase of PTEN would be
expected given the lack of glial scar sus-
tained by the drug-treated rats. As antic-
ipated, PTEN was highly expressed in
astrocytes at the level of the site of injury
in agonist-treated rats, but not in
vehicle-treated rats (Fig. 7G).
Because exosomes carry several proteins,
lipids, and RNA that can exert biological ac-
tivity in the recipient cells (Raposo and
Figure 4. Absence of glial scar in RAR-agonist-treated rats at the DREZ. A, Differences in astrocytes at the reimplantation site in vehicle- and RAR-agonist-treated rats. Scale bar, 100 m. B,
High-resolution Z-stack images of insets shown in A in which differences in astrocyte morphology and density at the DREZ is clear between the two groups. Scale bar, 20 m. C, Quantification of
GFAP. Results are mean  SEM. ***p  0.001, Student’s t test.
Figure 5. Fiber-tracking images of nerve roots in avulsed rats. The images (A–D) show rat SC specimens after ex vivo
imaging with a 9.4 T MRI scanner and after treatment in DSI studio software for tractography. A, SC from a rat subjected to
dorsal root avulsion and subsequent replantation into the dorsolateral spinal cord. This animal received RAR treatment
and tractography using the dorsolateral white matter as the origin for the tracing-indicated connection between the SC and
the replanted dorsal root (white arrows). B, In contrast, in an animal treated with the control vehicle, there was no
indication of connections between the white matter and the replanted root. C, D, Examples of tractography when the entire
ipsilateral white matter was used as the origin for tractography in a drug-treated animal (C) and a vehicle-treated animal
(D). Note the ventral root emerging in C. The arrows in C and D indicate the position of the replant site. The color code for
fibers running longitudinal to the spinal cord is blue, whereas fibers running perpendicular into the replant appear in green
and a sagittal direction is represented in red.
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Stoorvogel, 2013), we wanted to verify that this was a PTEN-
mediated event. To test this, neurons were transfected with a PTEN
siRNA or a scrambled siRNA and cultured with either vehicle or
CD2019. After 72 h, exosomes were extracted from the medium and
Western blotting confirmed that PTEN was knocked in both cell
lysates and in the exosomes from cultures treated with the PTEN
siRNA (Fig. 8A,B). This was further corroborated by immunostain-
ing of glial cultures treated with these exosomes for 24 h (Fig. 8
C,D). Next, we treated astrocytes for 24 h with PTEN-depleted
(from PTEN-siRNA-transfected neurons) or nondepleted (from
scrambled-siRNA-transfected neurons) exosomes from CD2019-
treated cultures and found that only the latter induced a significant
reduction in cell proliferation (Fig. 8E). This suggests that PTEN
plays a crucial role in modulating astrocyte proliferation.
To determine whether this paradigm was sustained in vivo, a pool
of exosomes was injected directly at the site of reimplantation of
avulsed dorsal roots into the SC (C5–C8, T1), with a group of ani-
mals receiving exosomes from CD2019-treated neurons; the other
group received exosomes from vehicle-treated cultures (Fig. 9A).
Confirmation of the appropriate target delivery of exosomes was
obtained by immunostaining of tissue removed from a subset of
animals of both groups that were killed the day after surgery. Re-
markably, analysis of serial longitudinal sections taken from 100 m
each side of the implantation/exosome injection site showed a dra-
matic increase of PTEN in astrocytes in animals that were injected
with CD2019-treated neuronal exosomes (Fig. 9B). To assess the
effect of this boost of PTEN in astrocytes, we looked at differences in
the glial population after 2 weeks, when the glial scar would have
formed (Cregg et al., 2014). It is noteworthy to point out that we only
looked at the astrocytic component of the scar and did not assess
other cell types that typically populate the scar core (Cregg et al.,
2014). There was a clear difference in GFAP-positive density popu-
lation and morphology between the two groups. The animals that
received exosomes from RAR-agonist-treated neuronal cultures
did not have an increased astrocyte population around the injury site
on either side of the DREZ and the astrocytes had long, thin, un-
branched processes resembling resting local fibrous glia (Fig. 9C).
The group treated with exosomes from vehicle-cultured neurons
showed a much denser population of astrocytes on either side of the
DREZ that were morphological strikingly different in that a mixture
of radial and elongated phenotypes were present with hypertrophic
processes that were entangled in each other (Fig. 9C). These are
known to act as a major physical barrier to regenerating axons
(Wanner et al., 2013). However, when we looked at regeneration
after 6 weeks of exosome treatment, we did not find any BDA-
labeled axons crossing into the SC in animals that received exosomes
from RAR-agonist-treated neurons, in which, despite pheno-
typic features of a glial scar at the injury site being absent, no
colabeled III tubulin–BDA axons could be seen crossing the
DREZ (Fig. 9D).
Figure 6. Movement of RAR and PTEN in response to 72 h treatment with the RAR agonist CD2019. A, Mouse cortical neurons (0 DIV) were treated with CD2019 (0.1 M) for 72 h and then
processed for cell fractionation and analyzed by Western blotting. Levels of both RAR and PTEN are reduced in the membrane fraction in cells treated with CD2019 versus vehicle control. B,
Quantitative analysis of protein levels are mean values expressed as fold of vehicle (independent-samples t test, *p  0.05). n  4 for all experiments. Error bars indicate  SEM. C, CD2019 induces
a rapid (visible at 60 min) movement of PTEN into the cytoplasm in cortical neurons. Insets illustrate the shift of PTEN from the neurites into the cell body. Scale bar, 20 m.
Goncalves et al. • Neuronal RAR Signaling Modulates PTEN Activity J. Neurosci., November 25, 2015 • 35(47):15731–15745 • 15739
Figure 7. RAR agonist modulates astrocyte proliferation via induction of PTEN secretion by neurons in exosomes. A, B, Western blots showing that PTEN is present in exosomes
secreted by neurons (A) and is enriched in exosomes derived from CD2019 (0.1 M)-treated neurons (B). Figure shows a ratio of exosomal PTEN to neuronal -actin. **p  0.01,
Student’s t test. C, Cell proliferation assay showing that neuronal exosomes enriched in PTEN hamper astrocyte proliferation in vitro. Data represent mean  SEM. ***p  0.001, one-way
ANOVA followed by Tukey’s test. D, PTEN is visible only in astrocytes treated with exosomes derived from CD2019-treated neurons. Scale bar, 20 and 50 m for the last column. E, F, There
is no change in PTEN nor phosphorylated PTEN (PTEN P) in astrocytes treated with CD2019 compared with vehicle-treated cultures, Data show mean  SEM, Student’s t test. G, PTEN is
present in astrocytes in the SC of RAR-agonist-treated rats but absent in vehicle-treated ones. Scale bar, 20 m.
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Because neurons also secrete exosomes and these can repre-
sent a mechanism of interneuronal communication (Chivet et al.,
2014), we next assessed whether the lack of axonal growth could
be due to interneuronal exosome exchange. Neurite outgrowth
was measured in cortical neurons treated with vehicle or CD2019
or exosomes from neuronal cultures that had been treated with
either vehicle or CD2019 for 72 h. We found that only CD2019
caused a significant increase in neurite outgrowth, with all of the
other treatments having no effect compared with control cultures
(Fig. 9E). This not only rules out a negative effect of interneuro-
nal exosome exchange on neuronal growth programs, but also
emphasizes that it is the RAR agonist modulation that is crucial.
Next, we sought to confirm that the increase in astrocytic
PTEN observed in the avulsed rats that received PTEN-enriched
exosome injections resulted from the uptake of those exosomes
rather than from an increase in endogenous expression. There-
fore, we treated avulsed rats with an exosome inhibitor alone
(GW4869, 1 mg/kg) and in conjunction with RAR agonist for 4
weeks. We then looked at PTEN expression 2 and 4 weeks later
and compared it with the one seen in RAR-agonist-treated rats
for the same period of time. We confirmed that the origin of the
PTEN in astrocytes of rats treated with the RAR agonist derives
essentially from the exosomes because there was little or no PTEN
in astrocytes in either GW4869-treated group at 2 weeks (Fig.
10A) and 4 weeks (Fig. 10B), but PTEN was abundant in astro-
cytes of RAR-agonist-treated rats after 2 weeks (Fig. 10A) and 4
weeks of treatment (Fig. 7E). Concurrently, the effects in glial
cells elicited by the exosome-derived PTEN were also absent
upon treatment with the exosome inhibitor and a glial scar with
densely entangled astrocytes at the DREZ was seen at 2 and 4
Figure 8. Loss of PTEN prevents neuronal exosome mediated modulation of astrocyte proliferation. A, Western blots showing that transfection of cortical neurons with PTEN siRNA
resulted in a loss of PTEN in the secreted exosomes (top) and in the cell lysates (bottom). B, Quantitative analysis of protein levels are mean values expressed as fold of control (scrambled
siRNA) after normalization for neuronal -actin. *p  0.05; ***p  0.001, Student’s t test. n  3 for all experiments. Error bars indicate  SEM. C, Expression of PTEN in astrocytes
cultured for 24 h with exosomes from scrambled or PTEN-siRNA-transfected neurons in the presence or absence of CD2019. Scale bar, 100 m. D, High-magnification images showing
that high levels of PTEN could only be seen in cultures treated with exosomes from scrambled-siRNA-transfected neurons treated with CD2019. Scale bar, 50 m. E, Cell proliferation
assay showing that only exosomes enriched in PTEN (from CD2019-scrambled siRNA-transfected neurons) modulate astrocyte proliferation in. Data represent mean  SEM. ***p 
0.001, one-way ANOVA followed by Tukey’s test.
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Figure 9. PTEN-enriched neuronal exosomes prevent scar formation after avulsion. A, Illustration of experimental design: exosomes isolated from CD2019- or vehicle-treated neurons were
injected into the pocket where the severed dorsal roots were reimplanted at the time of surgery. B, One day later, the presence of PTEN in astrocytes was assessed at the injection site and found to
have been taken up by astrocytes in animals that received PTEN-enriched exosomes. Scale bar, 15 m. C, Differences in astrocyte density and morphology at the reimplantation site between the two
groups. Right images (scale bar, 20 m) are insets from the images on the left (scale bar, 100 m). D, BDA-labeled axons at 6 weeks after surgery do not enter the SC and come to a stop before the
DREZ (arrows). Scale bar, 100 m. E, Treatment of cortical neurons with neuronal exosomes from cultures that had been treated either with vehicle or CD2019 had no effect in neurite outgrowth.
Only treatment with the RAR agonist caused a significant increase in neurite length. Data represent mean  SEM. *p  0.05, one-way ANOVA followed by Tukey’s test.
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weeks after surgery (Fig. 10A,B). Predict-
ably, inhibition of PTEN release in exo-
somes resulted in PTEN being mainly
located in the axons (Fig. 10C).
Discussion
True axonal regeneration after SC injury
has been difficult to verify due to the na-
ture of the models used, which convey
limited clinical translational applicability
because the lesion induced in the animal is
not equivalent to the human injury. In
this study, we have modeled in the rat a
human root avulsion that is usually in-
flicted by severe trauma to the forequarter
in road traffic accidents affecting mainly
young individuals. Here, we describe a
suitable animal model and a signaling
pathway that reprograms adult neuronal
paths and modulates glial activity, allow-
ing regeneration to occur. We identify a
novel mechanism of action for PTEN in
which it exerts a biological activity in as-
trocytes via neuronal exosome transfer to
prevent scar formation.
A dorsal root injury, although by defi-
nition situated in the PNS, is in effect an
SC or CNS lesion. Most previous studies
aimed at resolving the common human
traumatic clinical condition of root avul-
sion from the SC have investigated the ef-
fect of crushing the dorsal root, which is
not relevant as an experimental paradigm
(Wong et al., 2006). In this type of lesion,
it cannot be ruled out that spared axons
that sprout and lead to functional output
are present. The fact that a bridge to the
cord is maintained may allow a mecha-
nism of axonal regeneration to occur un-
related to the human injury, which is a
severing of the sensory axons entering the
SC. To overcome these limitations, we
modeled in the rat a human avulsion in-
jury. The roots were not exactly avulsed or
pulled out from their attachment with the
SC, but rather cut at the SC surface. There
is a certain difference between the two
traumas in that, with a true avulsion, there
would be some more secondary changes
within the SC, such as bleeding and cell
death (Chew et al., 2011). However, the
avulsion trauma is much more difficult to
standardize with regard to magnitude of
power of pull, direction, and so forth than
a clean cut, so the effect on the integrity of
Figure 10. Exosome inhibition prevents RAR–PTEN- induced modulation of the glial scar after avulsion. Avulsed rats were
treated with GW4869 alone or GW4869 and RAR agonist for 4 weeks after surgery. A, After 2 weeks of exosome inhibitor
treatment, PTEN could not be seen in astrocytes surrounding the lesioned area and a glial scar is present. In contrast, RAR-
agonist-treated rats show a considerable amount of PTEN in astrocytes and these do not form an entangled mesh, but rather
4
distribute in an elongated manner toward the SC. B, The same
pattern of expression of PTEN in astrocytes seen at 2 weeks is
observed at 4 weeks after surgery for both groups treated with
GW4869. Scale bar, 100 m. C, Treatment with exosome in-
hibitor for 4 weeks induces PTEN to remain in the axons. Scale
bar, 100 m.
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dorsal root axons would be the same. After dorsal root cut and
subsequent implantation into the SC, without any adjuvant ther-
apy, there is only minimal or abortive growth of dorsal root axons
in the SC (Carlstedt, 1985; Siegal et al., 1990). In our avulsion
system, we were able to show that activation of RAR signaling
induces regeneration of severed axons.
Of paramount importance is how the regenerated dorsal root
axons re-enter the SC. In the naive adult situation, there is a special-
ized “transitional region” between a stereotype peripheral nerve
compartment of the dorsal root and the central nervous fiber tracts
of the SC, which involves a number of unique structural entities
(Berthold and Carlstedt, 1977a). Among these are the occurrence of
fibrous astrocytic processes surrounding and separating the most
proximal peripheral nervous parts of the myelinated fibers, as well as
the formation of the compound PNS–CNS type of node of Ranvier
at the crossing of nerve fibers from the PNS to the CNS type of
organization (Berthold and Carlstedt, 1977b). Here, we show that
the regrowing dorsal root nerve fibers extend along a pathway very
much resembling the normal dorsal root PNS–CNS transitional re-
gion where fibrous astrocytic processes encase the most proximal
PNS paranode of individual myelinated fibers. It is also obvious
from the present results that there are compound PNS–CNS nodes
of Ranvier as the myelinated nerve fibers pass from the dorsal root
into the SC. These results suggest that reconstituting a naive tissue
organization at the PNS–CNS interface is important to allow for
nerve fiber regeneration into the SC and the CNS, but this new
observation has to be tested and studied further.
Dorsal root nerve fiber regeneration was also shown by BDA-
labeled axons crossing through the DREZ, as well as various proteins
that are upregulated during regeneration and involved in synaptic
activity across the SC and/or dorsal root. In addition, images of trac-
tography supported the possibility of a robust growth of axons from
the replanted dorsal root into the superficial dorsolateral white mat-
ter on the lesioned side of the SC. Hypothetically, the same type of
signal could be due to movements of water in glial processes. How-
ever, it seems less likely that individual glial processes actually would
be organized in parallel bundles extending from the PNS compart-
ment of the dorsal root into the dorsal funiculus. Collectively, these
data suggest that axonal regeneration took place and new connec-
tions were made in the dorsal horn. This indicates a switch from the
nonpermissive environment that sets after SCI into a favorable one.
Here, we show that RAR agonism modulates the PTEN signaling
pathway in neurons and in astrocytes. In neurons, RAR, via a cy-
toplasmic effect, induces PTEN to move from the membrane, where
it blocks axonal outgrowth via PI3K inhibition (Park et al., 2010),
into the cytoplasm, where it becomes phosphorylated and hence
inactive (Ross and Gericke, 2009). In addition, stimulation of RAR
results in an increased secretion of PTEN in exosomes. Recruitment
of PTEN into exosomes requires Ndfip 1 and PTEN ubiquitination
(Putz et al., 2012), which are also required for nuclear translocation
of PTEN (Trotman et al., 2007; Howitt et al., 2012). Although we did
not look directly at these two factors, we saw a significant increase of
nuclear PTEN in response to RAR agonist treatment. Given that
PTEN recruitment into both exosomes and the nucleus are gov-
erned by the same biological factors, it stands to reason that RAR
might induce the release of PTEN-enriched exosomes, at least in part
via ubiquitination and enrollment of Ndfip 1. In agreement with
this, it has been shown that RA induces PTEN ubiquitination (Song
et al., 2008), placing this mechanism as a likely candidate for the
generation of neuronal PTEN-enriched exosomes in response to
RAR agonist treatment. In astrocytes, RAR signaling does not
modulate PTEN in a direct manner, having no effect on endogenous
or exosome-secreted PTEN. Instead, it increases PTEN activity in
astrocytes via external uptake from neuronal exosomes. Only re-
cently has the importance of exosomes in fine-tuned cell-to-cell
communication come to light (Chivet et al., 2013). We have identi-
fied a mechanism that elucidates the cross talk between neurons and
astrocytes, in which PTEN is secreted from neurons in exosomes that
are taken up by astrocytes. This appears to be a physiological event
because PTEN was found in exosomes from vehicle-treated neu-
rons, but CD2019-treated cultures released exosomes significantly
enriched in PTEN. A similar non-cell-autonomous mode of PTEN
activity has been described recently in which PTEN secreted in exo-
somes alters the physiological state of the recipient cells (Putz et al.,
2012). This sheds new light into the PTEN function in adult regen-
eration, which has been largely perceived as solely inhibitory (Park et
al., 2010).
This exosome-derived boost in PTEN that reaches the astrocytes
is enough to hamper their proliferation, thus preventing the forma-
tion of a glial scar. PTEN negatively regulates PI3K/AKt signaling
and various studies in non-neuronal cells have identified mTOR as a
key downstream signal of PI3K/AKt in regulating cellular growth
(Sabatini, 2006; Abramov et al., 2009). The Rheb-mTOR pathway is
upregulated in reactive astrocytes of the injured SC (Codeluppi et al.,
2009), as is p-PTEN (inactive form) and p-AKt (active) in reactive
astrocytes in the rat ischemic hippocampus (Choi et al., 2005). It is
therefore likely that this is the pathway by which increased PTEN in
astrocytes reduces gliosis and scar size. Accordingly, we observed
that treatment with RAR agonist or PTEN-enriched exosomes (in-
jected at the injured site) resulted in a remarkably reduced scar and a
normal astrocytic phenotype. When the agonist was administered to
rats with an exosome inhibitor and when exosomes extracted from
neurons cultured in the presence of a PTEN siRNA were added to
glial cultures, the antiproliferative/glial modulation effects disap-
peared, corroborating our proposed signaling pathway of RAR-
induced neuron–glial PTEN transfer in exosomes. Interestingly,
when rats received PTEN-enriched exosomes at the injury site (and
no agonist treatment), there was no improvement in axonal regen-
eration. We did not investigate here whether these exosomes also
target and modulate other cell types involved in the formation of the
scar core, such as NG2 cells, microglia, and blood-borne macro-
phages (Cregg et al., 2014), but the considerable reduction/absence
of a glial scar certainly suggests this as a plausible situation. The lack
of axonal regeneration despite the absence of a glial scar may be
attributed to either the limited dose of PTEN-enriched exosomes
(just one injection); alternatively, to prevent scar formation, it may
simply not be not enough to induce sustained axonal regeneration in
the adult and a concomitant reprogramming of axonal internal
mechanisms may also be required.
In essence, we show here how neuronal RAR signaling mod-
ulates both neuronal and glial activity via the PTEN signaling
pathway, resulting in a permissive milieu that allows axonal re-
generation and functional recovery after cervical avulsion.
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